Stephen Sanders

Array ( [id] => 8221749 [patent_doc_number] => 20120135931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHOD OF MODIFYING SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/319051 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31176 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7755608 [patent_doc_number] => 20120028284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES' [patent_app_type] => utility [patent_app_number] => 13/263423 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 6287 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028284.pdf [firstpage_image] =>[orig_patent_app_number] => 13263423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958463 [patent_doc_number] => 20110182850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'ORGANIC COMPOUNDS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/755856 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36932 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182850.pdf [firstpage_image] =>[orig_patent_app_number] => 12755856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720809 [patent_doc_number] => 20120010144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Peg-albumin composition having at least one protected thiol region as a platform for medications' [patent_app_type] => utility [patent_app_number] => 13/138558 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3665 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010144.pdf [firstpage_image] =>[orig_patent_app_number] => 13138558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814558 [patent_doc_number] => 20130115603 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-05-09 [patent_title] => 'NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/262477 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26380 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814558 [patent_doc_number] => 20130115603 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-05-09 [patent_title] => 'NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/262477 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26380 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818503 [patent_doc_number] => 20120065123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Synthetic Antibodies' [patent_app_type] => utility [patent_app_number] => 13/256500 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 73 [patent_no_of_words] => 57987 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065123.pdf [firstpage_image] =>[orig_patent_app_number] => 13256500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670062 [patent_doc_number] => 20110319331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'NOVEL USES OF FIBRINOGEN' [patent_app_type] => utility [patent_app_number] => 13/254565 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982073 [patent_doc_number] => 08513187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Soft protease inhibitors, and pro-soft forms thereof' [patent_app_type] => utility [patent_app_number] => 13/203651 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19504 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657282 [patent_doc_number] => 20110306551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Modification of Factor VIII' [patent_app_type] => utility [patent_app_number] => 13/146760 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18937 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306551.pdf [firstpage_image] =>[orig_patent_app_number] => 13146760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292468 [patent_doc_number] => 20100239554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'EXTENDED RECOMBINANT POLYPEPTIDES AND COMPOSITIONS COMPRISING SAME' [patent_app_type] => utility [patent_app_number] => 12/699761 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 86489 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239554.pdf [firstpage_image] =>[orig_patent_app_number] => 12699761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7486059 [patent_doc_number] => 20110250702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ISOLATED PEPTIDES OF RABBIT FACTOR VII' [patent_app_type] => utility [patent_app_number] => 13/139400 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8118 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250702.pdf [firstpage_image] =>[orig_patent_app_number] => 13139400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501451 [patent_doc_number] => 20110263481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Pharmaceutical Composition of Lyophilized Formulation and Preparation Method of the Same' [patent_app_type] => utility [patent_app_number] => 13/141589 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4650 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263481.pdf [firstpage_image] =>[orig_patent_app_number] => 13141589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514360 [patent_doc_number] => 20100216725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => ' 4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION' [patent_app_type] => utility [patent_app_number] => 12/635270 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24735 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216725.pdf [firstpage_image] =>[orig_patent_app_number] => 12635270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413604 [patent_doc_number] => 08697641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => '4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication' [patent_app_type] => utility [patent_app_number] => 12/635049 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22975 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12635049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567969 [patent_doc_number] => 20110288032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'ENZASTAURIN FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/130104 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3274 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288032.pdf [firstpage_image] =>[orig_patent_app_number] => 13130104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580837 [patent_doc_number] => 20110294720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'APRATOXIN THERAPEUTIC AGENTS: MECHANISM AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/132010 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9004 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294720.pdf [firstpage_image] =>[orig_patent_app_number] => 13132010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510771 [patent_doc_number] => 20110256561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION' [patent_app_type] => utility [patent_app_number] => 13/140713 [patent_app_country] => US [patent_app_date] => 2009-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10108 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256561.pdf [firstpage_image] =>[orig_patent_app_number] => 13140713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063729 [patent_doc_number] => 20110245157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'DIMERIC 1-ARYLPYRAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/129031 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31532 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245157.pdf [firstpage_image] =>[orig_patent_app_number] => 13129031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320284 [patent_doc_number] => 20100113328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Targeted delivery to legumain-expressing cells' [patent_app_type] => utility [patent_app_number] => 12/589572 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113328.pdf [firstpage_image] =>[orig_patent_app_number] => 12589572 [rel_patent_id] =>[rel_patent_doc_number] =>)